Geographic Distribution of HCV Genotypes and Efficacy of Direct-Acting Antivirals in Chronic HCV-Infected Patients in North and Northeast China: A Real-World Multicenter Study

<div>Flowchart of chronic hepatitis C virus (HCV) infected patient enrollment and follow-up. DAAs: direct-acting antivirals; OBV/PTV/r: ombitasvir/paritaprevir/ritonavir; DSV: dasabuvir; SOF: sofosbuvir; RBV: ribavirin; EBR/GZR: elbasvir/grazoprevir; VEL: velpatasvir; DCV: daclatasvir; ASV: asunaprevir; LDV: ledipasvir; and GLE/PIB: glecaprevir/pibrentasvir.</div>

Canadian Journal of Gastroenterology and Hepatology

fig1

Figure 1

Figure 1: Geographic Distribution of HCV Genotypes and Efficacy of Direct-Acting Antivirals in Chronic HCV-Infected Patients in North and Northeast China: A Real-World Multicenter Study 

Figure 1 | Geographic Distribution of HCV Genotypes and Efficacy of Direct-Acting Antivirals in Chronic HCV-Infected Patients in North and Northeast China: A Real-World Multicenter Study 